FINANCIAL INFORMATION

In millions of USD (except for per share items)

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Statement of Cash Flows [Abstract]
Net cash provided by operating activities	$ 195,349	$ 209,808
Cash flows from investing activities:
Sale of investment securities	16,186	14,895
Maturities of investment securities	45,798	16,899
Purchase of investment securities	(76,094)	(22,516)
Purchase of long-term investments	(1,000)	0
Investments in real estate ventures	(36,269)	(6,132)
Distributions from investments in real estate ventures	30,934	37,819
Increase in cash surrender value of life insurance policies	(773)	(806)
Decrease in restricted assets	661	254
Proceeds from sale of fixed assets	17	0
Capital expenditures	(10,158)	(12,546)
Repayments of notes receivable	0	67
Purchase of subsidiaries	(323)	(370)
Pay downs of investment securities	828	1,293
Investments in real estate, net	(1,910)	(1,495)
Net cash (used in) provided by investing activities	(32,103)	27,362
Cash flows from financing activities:
Deferred financing costs	(36)	0
Repayments of debt	(230,874)	(1,490)
Borrowings under revolver	204,506	261,058
Repayments on revolver	(221,373)	(264,654)
Dividends and distributions on common stock	(179,449)	(169,571)
Distributions to non-controlling interest	(285)	(2,521)
Other	(46)	0
Net cash used in financing activities	(427,557)	(177,178)
Net (decrease) increase in cash, cash equivalents and restricted cash	(264,311)	59,992
Cash, cash equivalents and restricted cash, beginning of period	591,729	310,937
Cash, cash equivalents and restricted cash, end of period	$ 327,418	$ 370,929